A month after listing, Cerebras has Wall Street's full attention: ten buy ratings, an average target of $294 against a ~$241 price, Citigroup at $340 — and a valuation of 88 times sales, roughly ten times the tech-sector average. This is the market's chosen challenger to Nvidia.
| Metric | Value |
|---|---|
| Price | ~$241 |
| Avg. target | $294 (10 buys) |
| Top target | $340 (Citigroup) |
| 2025 revenue | $510M |
| 2025 non-GAAP loss | ~$76M |
| P/S ratio | 88x (sector ~9x) |
| Anchor deal | $10B OpenAI agreement + ~11% stake |
Why it moved
The bull case rests on architecture: Cerebras builds one wafer-sized chip instead of cutting wafers into hundreds of dies, claiming 250x the on-chip memory and 2,625x the memory bandwidth of Nvidia's B200. For inference workloads where memory bandwidth is the bottleneck, that is not an incremental edge — it is a different category. The $10 billion OpenAI agreement, with OpenAI taking an estimated 11% stake, is the proof the Street needed that a real buyer will commit at scale.
What it means for you
At 88x sales with widening losses ($76M in 2025), CBRS is priced for the OpenAI deal to be the first of many, not the only one. Customer concentration is the obvious risk — one anchor buyer with an equity stake is validation and dependency at once. Nvidia's software moat remains the structural counterargument.
Bottom line: I treat Cerebras like every priced-for-belief stock: small position or no position, never conviction-sized. The technology argument is real, but at this multiple you are paying today for a competitive war that has not been fought yet.